Related content

Ongoing trials involving angiotensin-converting enzyme inhibitors

By Nadar Sunil   Lip Gregory YH  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1633-1643

Informa Healthcare

Access to resources Recommend Favorite

Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors

By  

Current Pharmaceutical Design, Vol. 21, Iss. 13, 2015-04 ,pp. : 1764-1775

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of angiotensin II and angiotensin-converting enzyme inhibitors on human myocardium

By Lenz O.   Schmid B.   Kilter H.   La Rosee K.   Flesch M.   Kuhn-Regnier F.   Sudkamp M.   Bohm M.  

European Journal of Pharmacology, Vol. 294, Iss. 1, 1995-01 ,pp. : 17-27

Elsevier

Access to resources Recommend Favorite

Safety issues associated with the use of angiotensin-converting enzyme inhibitors

By Ehlers Mario R  

Expert Opinion on Drug Safety, Vol. 5, Iss. 6, 2006-11 ,pp. : 739-740

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin-converting enzyme inhibitors can potentiate ozone-induced airway hyperresponsiveness

By Matsubara S.   Kikkawa H.   Kaminuma O.   Ikezawa K.  

European Journal of Pharmacology, Vol. 337, Iss. 2, 1997-10 ,pp. : 259-265

Elsevier

Access to resources Recommend Favorite